Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/30/2012US20120220559 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/30/2012US20120220558 Methods of Treating Hormone-Related Conditions Using Thio-Oxindole Derivatives
08/30/2012US20120220557 Liquid propellant-free formulation comprising an antimuscarinic drug
08/30/2012US20120220556 Drospirenone for hormone replacement therapy
08/30/2012US20120220555 Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea
08/30/2012US20120220554 Combretastatins for Prevention of Posterior Capsule Opacification
08/30/2012US20120220553 The use of lpa for encouraging pregnancy, and fertility agent
08/30/2012US20120220552 (thio)morpholine derivatives as s1p modulators
08/30/2012US20120220551 Phosphorus containing compounds as protein kinase inhibitors
08/30/2012US20120220550 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
08/30/2012US20120220548 Compositions and methods for treatment of virus-associated cancer cells
08/30/2012US20120220547 Food formulation comprising glycogen
08/30/2012US20120220546 Compostions designed for the inhibition and/or blocking of the epithelial/mesenchymal transition
08/30/2012US20120220545 Coumarin compounds as melanogenesis modifiers and uses thereof
08/30/2012US20120220544 Ganglioside Transmucosal Formulations
08/30/2012US20120220543 Treatment of Glaucoma and Other Retinopathies with Gangliosides
08/30/2012US20120220537 9-aminoacridine derivatives, their preparation and uses
08/30/2012US20120220536 Use of endostatin peptides for the treatment of fibrosis
08/30/2012US20120220520 Bioavailable combinations for hcv treatment
08/30/2012US20120220518 Therapeutic agent delivery system and method
08/30/2012US20120220457 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF, AND METHODS OF USING SAME
08/30/2012US20120220453 Pesticidal compostions and processes related thereto
08/30/2012US20120219970 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
08/30/2012US20120219647 Antioxidant composition
08/30/2012US20120219643 Anti-neoplastic compositions comprising extracts of black cohosh
08/30/2012US20120219641 5-ht3 receptor modulators, methods of making, and use thereof
08/30/2012US20120219639 Nutritional supplement for patients with chronic heart failure
08/30/2012US20120219631 Modified release formulation of lacosamide
08/30/2012US20120219630 Treatment of Urinary Incontinence Using Nitrone Spin Traps
08/30/2012US20120219626 Pharmaceutical Compositions of Sevelamer
08/30/2012US20120219625 Clarithromycin extended-release tablet
08/30/2012US20120219623 Pharmaceutical compositions comprising bi-1356 and metformin
08/30/2012US20120219622 Dpp iv inhibitor formulations
08/30/2012US20120219621 Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
08/30/2012US20120219620 SCF Extract Containing Cardiac Glycoside
08/30/2012US20120219619 Substances for reducing occurrence of major cardiac events in humans
08/30/2012US20120219615 Therapeutic Use of a TLR Agonist and Combination Therapy
08/30/2012US20120219613 Novel Antiviral Agents for Enveloped Viruses
08/30/2012US20120219611 Hypotensive lipid-containing biodegradable intraocular implants and related methods
08/30/2012US20120219610 Bar Compositions Comprising Platelet Zinc Pyrithione
08/30/2012US20120219602 Methods for treating herpes virus infections
08/30/2012US20120219601 Composition Comprising Biodegradable Hydrating Ceramics for Controlled Drug Delivery
08/30/2012US20120219600 Polymer conjugated protein micelles
08/30/2012US20120219599 Osteogenic promoting implants and methods of inducing bone growth
08/30/2012US20120219598 Polymeric micelles for reducing ldl in vivo
08/30/2012US20120219597 Pharmaceutical formulations for indibulin
08/30/2012US20120219596 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
08/30/2012US20120219594 Benzimidazole-imidazole Derivatives
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219583 Nucleic acid sequences encoding expandable hiv mosaic proteins
08/30/2012US20120219581 Methods and formulations for treating chronic liver disease
08/30/2012US20120219577 Hiv-1 clade a consensus sequences, antigens, and transgenes
08/30/2012US20120219571 Combination motif immune stimulatory oligonucleotides with improved activity
08/30/2012US20120219568 Epidithiodioxopiprazines and uses thereof in treating cancer
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219561 Prophylaxis Against Cancer Metastasis
08/30/2012US20120219550 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor
08/30/2012US20120219544 Adhesive composition for soft tissues, adhesive composition for wound dressing or wound dressing composition
08/30/2012US20120219543 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis
08/30/2012US20120219542 Podocyte ph modulation and uses thereof
08/30/2012US20120219541 Therapeutic Compositions Comprising Monoterpenes
08/30/2012US20120219540 Compositions and methods for modulating immune responses
08/30/2012US20120219536 Purine-targeted diagnosis and therapy of wounds
08/30/2012US20120219534 Freeze-dried fibrin matrices and methods for preparation thereof
08/30/2012US20120219529 Silver ion compositions of pectins
08/30/2012US20120219525 Stable thickener formulations
08/30/2012US20120219522 Substituted quinoline compounds and methods of use
08/30/2012US20120219521 Methods and compositions to treat myocardial conditions
08/30/2012US20120219514 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
08/30/2012US20120219509 Guanidine-containing compounds useful as muscarinic receptor antagonists
08/30/2012US20120219508 Cellulose-based nanoparticles for drug delivery
08/30/2012US20120219502 Methods and compositions for targeting gc1qr/p32
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012US20120216802 Composition for inhalation
08/30/2012US20120216801 Treprostinil administration by inhalation
08/30/2012DE102011012343A1 Phenalen-1-on-Derivate, Verfahren zur Herstellung und Verwendung derselben Phenalen-1-one derivatives, to processes for preparing and using the same
08/30/2012CA2828495A1 Anti-viral compounds
08/30/2012CA2828360A1 Chrysophaentin analogs that inhibit ftsz protein
08/30/2012CA2828255A1 Protein nanocarriers for topical delivery
08/30/2012CA2828253A1 Polymer conjugated protein micelles
08/30/2012CA2828251A1 2-amino-naphthyridine derivatives
08/30/2012CA2828212A1 Inhibitors of bromodomains as modulators of gene expression
08/30/2012CA2828134A1 Composition to increase joint and/or postural stability
08/30/2012CA2828098A1 Pharmaceutical formulation comprising compounds jasmonate family
08/30/2012CA2827782A1 Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine
08/30/2012CA2827747A1 Pharmaceutical compositions of maraviroc and process for the preparation thereof
08/30/2012CA2827716A1 Stabilized granules containing glyceryl trinitrate
08/30/2012CA2827714A1 Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
08/30/2012CA2827578A1 Use of polyaminoisoprenyl derivatives in antibiotic or antiseptic treatment
08/30/2012CA2827567A1 Novel compounds as histamine h3 receptor ligands
08/30/2012CA2827474A1 C-4" position substituted macrolide derivative
08/30/2012CA2827372A1 Glycine transporter-inhibiting substances
08/30/2012CA2827336A1 Flumazenil complexes, compositions comprising same and uses thereof
08/30/2012CA2827239A1 Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
08/30/2012CA2827072A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2827057A1 Crystalline forms and processes for the preparation of condensed azacycles (cannabinoid receptor modulators)
08/30/2012CA2827030A1 Diaminopyrimidine derivatives and processes for the preparation thereof
08/30/2012CA2826892A1 Phosphorus containing compounds as protein kinase inhibitors
08/30/2012CA2826792A1 Heteroaryl derivatives as alpha7 nachr modulators
1 ... 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 ... 7860